Bioject Medical Technologies In
(BJCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2007 | 09-2007 | 06-2007 | 03-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,038 | -3,716 | -3,092 | -2,114 | -6,997 |
| Depreciation Amortization | 1,003 | 717 | 466 | 235 | 1,545 |
| Accounts receivable | 476 | 465 | 650 | -25 | 1,067 |
| Accounts payable and accrued liabilities | 473 | 135 | -36 | 274 | -669 |
| Other Working Capital | -6 | 217 | 753 | 497 | -1,015 |
| Other Operating Activity | 608 | 609 | 74 | 140 | 2,691 |
| Operating Cash Flow | $-1,484 | $-1,574 | $-1,185 | $-992 | $-3,378 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,009 | 225 | -25 | N/A | -175 |
| PPE Investments | -108 | -102 | -69 | -13 | 953 |
| Other Investing Activity | -271 | -173 | -173 | -83 | -197 |
| Investing Cash Flow | $630 | $-49 | $-267 | $-96 | $581 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -593 | 510 | 55 | 5 | 2,434 |
| Debt Issued | 1,715 | N/A | N/A | N/A | 500 |
| Debt Repayment | -547 | -34 | -23 | -12 | -2,055 |
| Common Stock Issued | 52 | 31 | 31 | N/A | 86 |
| Other Financing Activity | -28 | -250 | -167 | -83 | 2,764 |
| Financing Cash Flow | $599 | $257 | $-104 | $-90 | $3,729 |
| Beginning Cash Position | 1,978 | 1,978 | 1,978 | 1,978 | 1,045 |
| End Cash Position | 1,723 | 611 | 421 | 800 | 1,978 |
| Net Cash Flow | $-255 | $-1,366 | $-1,556 | $-1,178 | $932 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,484 | -1,574 | -1,185 | -992 | -3,378 |
| Capital Expenditure | -108 | -102 | -69 | -13 | -110 |
| Free Cash Flow | -1,592 | -1,676 | -1,254 | -1,004 | -3,487 |